iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)

ISIN IE00BDZVHG35

 | 

Ticker BTEE

TER
0.35% p.a.
Distribution policy
Distributing
Replication
Sampling
Fund size
29 m
Holdings
222
 

Overview

Description

The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) seeks to track the Nasdaq Biotechnology index. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.
 
The ETF's TER (total expense ratio) amounts to 0.35% p.a.. The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is the cheapest ETF that tracks the Nasdaq Biotechnology index. The ETF replicates the performance of the underlying index by sampling technique (buying a selection of the most relevant index constituents). The dividends in the ETF are distributed to the investors (Semi annually).
 
The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is a small ETF with 29m GBP assets under management. The ETF was launched on 5 March 2018 and is domiciled in Ireland.
Show more Show less

Chart

Basics

Data

Index
Nasdaq Biotechnology
Investment focus
Equity, United States, Health Care
Fund size
GBP 29 m
Total expense ratio
0.35% p.a.
Replication Physical (Optimized sampling)
Legal structure ETF
Strategy risk Long-only
Sustainability No
Fund currency USD
Currency risk Currency unhedged
Volatility 1 year (in GBP)
18.09%
Inception/ Listing Date 5 March 2018
Distribution policy Distributing
Distribution frequency Semi annually
Fund domicile Ireland
Fund Provider iShares
Germany 30% tax rebate
Switzerland ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Indextype Total return index
Swap counterparty -
Collateral manager Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank
Securities lending Yes
Securities lending counterparty Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG

Similar ETFs

This section provides you with information on other ETFs with a similar investment focus to the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
Similar ETFs via ETF search
How do you like our new ETF profile? Here you'll find our Questionnaire.

Holdings

Below you find information about the composition of the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

Top 10 Holdings

Weight of top 10 holdings
out of 222
48.11%
Vertex Pharmaceuticals
8.73%
Regeneron Pharmaceuticals
8.63%
Amgen
7.47%
Gilead Sciences
6.93%
AstraZeneca PLC ADR
3.65%
Moderna
3.60%
Biogen
3.22%
Illumina
2.27%
Alnylam Pharmaceuticals
1.94%
BioMarin Pharmaceutical
1.67%

Countries

United States
83.31%
Ireland
1.42%
Bermuda
1.02%
Other
14.25%

Sectors

Health Care
88.80%
Other
11.20%
As of 29/02/2024

Performance

The performance numbers include distributions/dividends (if there are any). By default, the total performance of the ETF is displayed.

Returns overview

YTD -4.01%
1 month -4.96%
3 months -4.77%
6 months +5.93%
1 year -3.81%
3 years -4.62%
5 years +32.48%
Since inception (MAX) +31.85%
2023 -1.18%
2022 +0.11%
2021 +1.04%
2020 +21.63%

Monthly returns in a heat map

Dividends

Current dividend yield

Current dividend yield 0.41%
Dividends (last 12 months) GBP 0.02

Historic dividend yields

Period Dividend in GBP Dividend yield in %
1 Year GBP 0.02 0.39%
2023 GBP 0.02 0.39%
2022 GBP 0.02 0.43%
2021 GBP 0.01 0.25%
2020 GBP 0.01 0.22%

Dividend yield contribution

Monthly dividends in GBP

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 18.09%
Volatility 3 years 23.86%
Volatility 5 years 26.00%
Return per risk 1 year -0.21
Return per risk 3 years -0.07
Return per risk 5 years 0.22
Maximum drawdown 1 year -12.80%
Maximum drawdown 3 years -30.89%
Maximum drawdown 5 years -30.89%
Maximum drawdown since inception -30.89%

Rolling 1 year volatility

Stock exchange

Listings

Listing Trade Currency Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
gettex EUR OM3E -
-
-
-
-
London Stock Exchange USD BTEE BTEE LN
INAVBTDU
BTTE.L

Further information

Further ETFs on the Nasdaq Biotechnology index

Fund name Fund Size in m € (AuM) TER p.a. Distribution Replication
iShares Nasdaq US Biotechnology UCITS ETF 410 0.35% p.a. Accumulating Sampling
Invesco Nasdaq Biotech UCITS ETF 390 0.40% p.a. Accumulating Swap-based

Frequently asked questions

What is the name of BTEE?

The name of BTEE is iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

What is the ticker of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?

The primary ticker of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is BTEE.

What is the ISIN of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?

The ISIN of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is IE00BDZVHG35.

What are the costs of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?

The total expense ratio (TER) of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) amounts to 0.35% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) paying dividends?

Yes, iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is paying dividends. Usually, the dividend payments take place semi annually for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

What's the fund size of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)?

The fund size of iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is 29m GBP. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.